IGFBP2 from a novel copper metabolism-associated biomarker promoted glioma progression and response to immunotherapy.
Luo Q, Zhuang J, Zheng D, Miao C, Luo H, Peng J, Zheng C, Qin C, Lan C, Chen M, Xia Y, Huang D, Chen Z.
Luo Q, et al. Among authors: chen z, chen m.
Front Immunol. 2023 Oct 19;14:1282734. doi: 10.3389/fimmu.2023.1282734. eCollection 2023.
Front Immunol. 2023.
PMID: 37928523
Free PMC article.